Could oxytocin reduce autoimmune disease in COVID-19?

https://doi.org/10.1016/j.autrev.2021.102994Get rights and content

Abstract

Disruption of immune and neuroendocrine system function has been shown to play a key role in COVID-19. Oxytocin is vitally important for the immune and neuroendocrine systems. However, oxytocin dysfunction might occur in COVID-19 leading to autoimmune disease. Intranasal oxytocin may be effective in turning off an overactive immune system. This could be a powerful approach to avoid possible autoimmune diseases after COVID-19.

Keywords

COVID-19
Oxytocin
Hypothalamus
Immune-neuroendocrine system
Autoimmune diseases
Intranasal administration

Cited by (0)

View Abstract